Serguei Melnitchouk, M.D.
This page shows the publications co-authored by Serguei Melnitchouk and Philicia Moonsamy.
Moonsamy P, Mohan N, Melnitchouk S. Optimal Anticoagulation After Tissue Aortic and Mitral Valve Replacement. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2):197-201.
Axtell AL, Moonsamy P, Dal-Bianco JP, Passeri JJ, Sundt TM, Melnitchouk S. Minimally Invasive Nonresectional Mitral Valve Repair Can Be Performed With Excellent Outcomes. Ann Thorac Surg. 2020 02; 109(2):437-444.
Osho AA, Moonsamy P, Ethridge BR, Leya GA, D'Alessandro DA, Jassar AS, Villavicencio MA, Melnitchouk SI, Tolis G, Langer NB, Funamoto M, Li SS, Colon KM, Mohan N, Locascio JJ, Lubitz SA, Akeju O, Sundt TM. Rationale and Design of the Randomized Controlled Trial of New Oral Anticoagulants vs. Warfarin for post Cardiac Surgery Atrial Fibrillation: The NEW-AF Trial. Ann Surg. 2020 Sep 01.
Axtell AL, Moonsamy P, Melnitchouk S, Tolis G, D'Alessandro DA, Villavicencio MA. Increasing donor sequence number is not associated with inferior outcomes in lung transplantation. J Card Surg. 2020 Feb; 35(2):286-293.
Axtell AL, Moonsamy P, Melnitchouk S, Jassar AS, Villavicencio MA, D'Alessandro DA, Tolis G, Cameron DE, Sundt TM. Starting elective cardiac surgery after 3 pm does not impact patient morbidity, mortality, or hospital costs. J Thorac Cardiovasc Surg. 2020 06; 159(6):2314-2321.e2.
Axtell AL, Moonsamy P, Melnitchouk S, Tolis G, Jassar AS, D'Alessandro DA, Villavicencio MA, Cameron DE, Sundt TM. Preoperative predictors of new-onset prolonged atrial fibrillation after surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2020 04; 159(4):1407-1414.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.